13F Holdings
中文EN

LUCD Lucid Diagnostics Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1799011 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY23.6%
TTM net income YoY8.9%
TTM EPS YoY—
Revenue 3-yr CAGR53.6%
Net income 3-yr CAGR—

Margins

Gross margin-16.5%
Operating margin-941.7%
Net margin-892.8%
FCF margin-953.3%
EBITDA margin-925.5%

Returns

ROE-305.6%
ROA-119.8%
ROIC (approx.)—
Asset turnover0.13x

Leverage & solvency

Liabilities / assets78.7%
Debt / equity0.00x
Current ratio1.20x
Interest coverage-3,011.88x

Cash quality & payout

Operating cash flow / net income1.06x
Accruals ratio7.4%
Payout ratio—
Capex / revenue5.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.20M$1.47M$1.26M$1.50M$1.21M$1.16M$828,000$1.20M
Cost of revenue$1.40M$1.45M$1.62M$1.86M$1.70M$1.56M$1.55M—
Gross profit-$201,000$29,000-$369,000-$356,000-$486,000-$400,000-$723,000—
R&D expense$1.18M$1.19M$1.21M$1.72M$1.27M$1.25M$1.43M$1.45M
SG&A expense$5.54M$5.76M$5.43M$6.48M$5.61M$5.62M$6.16M$5.86M
Operating income-$12.28M-$12.80M-$12.11M-$14.01M-$11.76M-$11.38M-$12.49M-$12.38M
Interest expense$1,000$4,000$6,000$6,000$2,000$6,000$9,000$7,000
Pretax income-$6.68M-$11.69M-$13.91M-$16.27M-$10.40M-$4.44M-$26.91M-$11.54M
Income tax$0$0$0$0$0$0$0—
Net income-$6.68M-$11.69M-$13.91M-$16.27M-$10.40M-$4.44M-$26.91M-$11.54M
EBITDA-$12.05M-$12.58M-$11.89M-$13.80M-$11.54M-$11.16M-$12.27M-$12.15M
EPS (basic)-0.03-0.08-0.17—-0.10-0.08-0.52—
EPS (diluted)————-0.10-0.08-0.52—
Weighted avg. shares (diluted)————108.18M98.99M68.80M—
Balance sheet
Cash & equivalents$17.99M$33.40M$27.88M$34.70M$47.33M$31.12M$25.24M$22.36M
Receivables$843,000$1.09M$689,000$643,000$550,000$373,000$61,000$45,000
Inventory$520,000$484,000$469,000$353,000$486,000$505,000$484,000$341,000
Current assets$25.96M$36.62M$31.36M$37.47M$49.84M$33.83M$27.54M$25.15M
PP&E, net$706,000$810,000$907,000$809,000$862,000$948,000$1.04M$1.06M
Intangibles$0$105,000$210,000$315,000$421,000$526,000$631,000$736,000
Total assets$27.86M$38.95M$34.08M$40.45M$53.20M$38.67M$32.80M$30.71M
Current liabilities$21.65M$27.52M$29.39M$28.58M$26.21M$29.43M$36.57M$23.52M
Total liabilities$21.93M$28.02M$30.08M$29.51M$27.36M$30.81M$38.17M$25.32M
Shareholders' equity$5.93M$10.93M$4.00M$10.94M$25.84M$7.86M-$5.38M$5.39M
Shares outstanding190.97M190.76M164.88M131.10M130.92M101.83M84.37M63.07M
Cash flow statement
Operating cash flow-$15.55M-$11.30M-$12.10M-$12.58M-$10.89M-$10.55M-$12.46M-$9.87M
Capital expenditure$17,000$21,000$215,000$51,000$28,000$25,000$93,000—
Free cash flow-$15.57M-$11.32M-$12.32M-$12.63M-$10.92M-$10.57M-$12.56M—
Investing cash flow-$17,000-$21,000-$215,000-$51,000-$28,000-$25,000-$93,000-$259,000
Financing cash flow$156,000$16.85M$5.49M$2,000$27.13M$16.46M$15.44M$18.00M
Depreciation & amortization$225,000$224,000$222,000$209,000$220,000$222,000$221,000$222,000
Stock-based compensation$1.45M$1.69M$1.41M$1.26M$1.15M$1.14M$1.03M$1.50M

Free plan shows the latest 8 periods; Pro shows all 25 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.